Qiagen N.V.

Analysts Estimate Qiagen (QGEN) to Report a Decline in Earnings: What to Look Out for

Qiagen (QGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo Finance · 29/07/2026 · lire l'article ↗

KKR (KKR) After Qiagen Interest And Allyntra Launch Has Valuation Back In Focus

KKR stock in focus after Qiagen interest and medtech platform launch KKR (KKR) is back in the spotlight after reports linked the firm to potential takeover interest in Qiagen and it announced Allyntra, a new precision engineered medtech platform. See our latest analysis for KKR. Despite the Qiagen interest and the launch of Allyntra, KKR’s share price has been under pressure, with a year to date share price return down 25.89% and a 1 year total shareholder return down 35.14%, although the 3...

Yahoo Finance · 23/07/2026 · lire l'article ↗

KKR (KKR) Launches Allyntra While Chasing DStelecom And Qiagen

KKR (NYSE:KKR) has launched Allyntra, a precision-engineered solutions platform focused on advanced surgical technologies in medical technology. The company is pursuing a controlling stake in Portuguese fiber operator DStelecom, aiming to expand its presence in digital infrastructure. KKR has also been identified as a potential bidder in early takeover discussions for healthcare-focused Qiagen. KKR, trading at around $97.11 per share, is adding fresh moves in medtech and infrastructure to...

Yahoo Finance · 22/07/2026 · lire l'article ↗

Cancer Biomarkers Market to Reach US$ 54.48 Billion by 2032 as Precision Oncology and Multi-Omics Adoption Accelerate

Asia-Pacific will be the fastest-growing region. Key players include Roche, Thermo Fisher, Illumina, Agilent Technologies, and QIAGEN. Cancer Biomarkers Market Cancer Biomarkers Market Dublin, July 17, 2026 (GLOBE NEWSWIRE) -- The "Cancer Biomarkers Market by Profiling Technology, Cancer, Product, Application, End User, And Region - Global Forecast to 2032" has been added to ResearchAndMarkets.com's offering. Global market forecast indicates an 11.6% CAGR, with diagnostic laboratories holding th

Yahoo Finance · 17/07/2026 · lire l'article ↗

QIAGEN Highlights Molecular Testing Solutions Supporting Response to Growing U.S. Cyclospora Outbreak

GERMANTOWN, Md., & VENLO, Netherlands, July 15, 2026--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today highlighted its portfolio of molecular testing solutions supporting the public health response to the growing number of cyclosporiasis cases reported across the United States.

Yahoo Finance · 15/07/2026 · lire l'article ↗

QIAGEN N.V. to Release Results for Q2 2026 and Hold Webcast

VENLO, Netherlands, July 15, 2026--QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today announced plans to release results for the second quarter of 2026.

Yahoo Finance · 15/07/2026 · lire l'article ↗